Literature DB >> 22705815

Aristolochic acid nephropathy.

M Refik Gökmen, Graham M Lord.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22705815     DOI： 10.1136/bmj.e4000

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.

Authors:  Bojan Jelaković; Xavier Castells; Karla Tomić; Maude Ardin; Sandra Karanović; Jiri Zavadil
Journal:  Int J Cancer       Date:  2014-12-10       Impact factor: 7.396

2.  Preventing aristolochic acid nephropathy.

Authors:  Nelomi Anandagoda; Graham M Lord
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-13       Impact factor: 8.237

3.  Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

4.  Chapter 5: Referral to specialists and models of care.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

5.  Morphological and clinical findings in Sri Lankan patients with chronic kidney disease of unknown cause (CKDu): Similarities and differences with Mesoamerican Nephropathy.

Authors:  Julia Wijkström; Channa Jayasumana; Rajeewa Dassanayake; Nalin Priyawardane; Nimali Godakanda; Sisira Siribaddana; Anneli Ring; Kjell Hultenby; Magnus Söderberg; Carl-Gustaf Elinder; Annika Wernerson
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

Review 6.  Environmental toxin-induced acute kidney injury.

Authors:  Benjamin A Vervaet; Patrick C D'Haese; Anja Verhulst
Journal:  Clin Kidney J       Date:  2017-07-28

7.  Mitochondrial Iron Overload-Mediated Inhibition of Nrf2-HO-1/GPX4 Assisted ALI-Induced Nephrotoxicity.

Authors:  Hui-Fang Deng; Lan-Xin Yue; Ning-Ning Wang; Yong-Qiang Zhou; Wei Zhou; Xian Liu; Yu-Hao Ni; Cong-Shu Huang; Li-Zhen Qiu; Hong Liu; Hong-Ling Tan; Xiang-Lin Tang; Yu-Guang Wang; Zeng-Chun Ma; Yue Gao
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.